Results: 1-25 | 26-33
Results: 1-25/33

Authors: Arase, Y Chayama, K Ikeda, K Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Suzuki, F Akuta, N Someya, T Kobayashi, M Kumada, H
Citation: Y. Arase et al., Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C, HEPATOL RES, 21(1), 2001, pp. 55-66

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration, HEPATOL RES, 19(1), 2001, pp. 22-30

Authors: Murashima, N Ikeda, K Kobayashi, M Saitoh, S Chayama, K Tsubota, A Suzuki, Y Suzuki, F Arase, Y Kumada, H
Citation: N. Murashima et al., Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis, J GASTRO, 36(6), 2001, pp. 368-374

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen, J GASTRO, 36(4), 2001, pp. 242-247

Authors: Someya, T Suzuki, Y Arase, Y Kobayashi, M Suzuki, F Tsubota, A Saitoh, S Chayama, K Murashima, N Ikeda, K Kumada, H
Citation: T. Someya et al., Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant, J GASTRO, 36(2), 2001, pp. 133-136

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Pathogenic significance and organic virus levels in patients infected withTT virus, INTERVIROLO, 44(5), 2001, pp. 291-297

Authors: Chayama, K Suzuki, F Tsubota, A Akuta, N Someya, T Kobayashi, M Arase, Y Saitoh, S Suzuki, Y Ikeda, K Kumada, H
Citation: K. Chayama et al., Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype, J VIROL MET, 95(1-2), 2001, pp. 33-45

Authors: Akuta, N Chayama, K Suzuki, F Someya, T Kobayashi, M Tsubota, A Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: N. Akuta et al., Risk factors of hepatitis C virus-related liver cirrhosis in young adults:Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2)0201 allele, J MED VIROL, 64(2), 2001, pp. 109-116

Authors: Tsubota, A Arase, Y Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Chayama, K Murashima, N Ikeda, K Kobayashi, M Kumada, H
Citation: A. Tsubota et al., Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study, AM J GASTRO, 96(2), 2001, pp. 557-562

Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Tsubota, A Suzuki, F Arase, Y Murashima, N Chayama, K Kumada, H
Citation: K. Ikeda et al., Distinction between chronic hepatitis and liver cirrhosis in patients withhepatitis C virus infection. Practical discriminant function using common laboratory data, HEPATOL RES, 18(3), 2000, pp. 252-266

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course, J GASTRO, 35(8), 2000, pp. 607-612

Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Tsubota, A Arase, Y Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma, J GASTRO, 35(5), 2000, pp. 353-360

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C, J GASTRO, 35(3), 2000, pp. 221-225

Authors: Kobayashi, M Chayama, K Arase, Y Tsubota, A Saitoh, S Suzuki, Y Kobayashi, M Murashima, N Ikeda, K Hagiwara, M Hashimoto, R Nakagawa, M Matsuda, M Kumada, H
Citation: M. Kobayashi et al., Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance, J GASTRO, 35(10), 2000, pp. 753-757

Authors: Kobayashi, M Ikeda, K Akuta, N Someya, T Suzuki, F Tsubota, A Suzuki, Y Saitoh, S Arase, Y Chayama, K Kumada, H
Citation: M. Kobayashi et al., Relationship between five-year histological outcome and serial changes in serum alanine aminotransferase in patients with biochemical and virologicalrelapse after interferon treatment for chronic hepatitis C, INTERVIROLO, 43(3), 2000, pp. 174-179

Authors: Chayama, K Suzuki, F Tsubota, A Kobayashi, M Arase, Y Saitoh, S Suzuki, Y Murashima, N Ikeda, K Takahashi, N Kinoshita, M Kumada, H
Citation: K. Chayama et al., Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy, HEPATOLOGY, 32(5), 2000, pp. 1138-1144

Authors: Ikeda, K Arase, Y Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Tsubota, A Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer, HEPATOLOGY, 32(2), 2000, pp. 228-232

Authors: Kobayashi, M Ikeda, K Saitoh, S Suzuki, F Tsubota, A Suzuki, Y Arase, Y Murashima, N Chayama, K Kumada, H
Citation: M. Kobayashi et al., Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis, CANCER, 88(11), 2000, pp. 2471-2477

Authors: Tsubota, A Kumada, H Arase, Y Chayama, K Saitoh, S Ikeda, K Kobayashi, M Suzuki, Y Murashima, N
Citation: A. Tsubota et al., Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients, EUR J GASTR, 11(10), 1999, pp. 1077-1083

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Nakamura, I Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Kobayashi, M Kumada, H
Citation: Y. Arase et al., Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy, J GASTRO, 34(5), 1999, pp. 594-599

Authors: Kobayashi, M Chayama, K Arase, Y Tsubota, A Saitoh, S Suzuki, Y Kobayashi, M Ikeda, K Matsuda, M Koike, H Hashimoto, M Kumada, H
Citation: M. Kobayashi et al., Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6, J GASTRO, 34(4), 1999, pp. 505-509

Authors: Kobayashi, M Chayama, K Arase, Y Tsubota, A Saitoh, S Suzuki, Y Kobayashi, M Kobayashi, M Ikeda, K Matsuda, M Koike, H Hasimoto, M Kumada, H
Citation: M. Kobayashi et al., Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon alpha, J GASTRO, 34(1), 1999, pp. 94-99

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, H Kobayashi, M Kobayashi, M Kumada, H
Citation: Y. Arase et al., Efficacy and changes of the nonstructural 5A gene by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level ofserum HCV-RNA, INTERN MED, 38(6), 1999, pp. 461-466

Authors: Kobayashi, M Chayama, K Arase, Y Kobayashi, M Tsubota, A Suzuki, Y Koida, I Saitoh, S Murashima, N Ikeda, K Koike, H Hashimoto, M Kobayashi, M Kumada, H
Citation: M. Kobayashi et al., Prevalence of TT virus before and after blood transfusion in patients withchronic liver disease treated surgically for hepatocellular carcinoma, J GASTR HEP, 14(4), 1999, pp. 358-363

Authors: Ikeda, K Saitoh, S Arase, Y Chayama, K Suzuki, Y Kobayashi, M Tsubota, A Kobayashi, M Nakamura, I Murashima, N Kumada, H Kawanishi, M
Citation: K. Ikeda et al., Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis, HEPATOLOGY, 29(4), 1999, pp. 1124-1130
Risultati: 1-25 | 26-33